{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:29:56Z","timestamp":1772605796681,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"vor","delay-in-days":430,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1038\/s41379-021-00860-4","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T08:02:46Z","timestamp":1624694566000},"page":"2064-2070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4413-5623","authenticated-orcid":false,"given":"Tim","family":"Hansum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2406-5370","authenticated-orcid":false,"given":"Eva","family":"Hollemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2734-0254","authenticated-orcid":false,"given":"Esther I.","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris H.","family":"Bangma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Rietbergen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Osanto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6328-6462","authenticated-orcid":false,"given":"Rob C.M.","family":"Pelger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5773-7730","authenticated-orcid":false,"given":"Tom","family":"van Wezel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henk","family":"van der Poel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise","family":"Bekers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozien","family":"Helleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastiaan","family":"Remmers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2176-9102","authenticated-orcid":false,"given":"Geert J. L.H.","family":"van Leenders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-021-00860-4_bib1","first-page":"125","article-title":"Classification of prostatic carcinomas","volume":"50","author":"Gleason","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"10.1038\/s41379-021-00860-4_bib2","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/01.pas.0000173646.99337.b1","article-title":"The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma","volume":"29","author":"Epstein","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00860-4_bib3","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00860-4_bib4","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/PAS.0b013e3182556dcd","article-title":"Do adenocarcinomas of the prostate with Gleason score (GS) <\/=6 have the potential to metastasize to lymph nodes?","volume":"36","author":"Ross","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00860-4_bib5","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.juro.2010.10.057","article-title":"Predicting 15-year prostate cancer specific mortality after radical prostatectomy","volume":"185","author":"Eggener","year":"2011","journal-title":"J Urol"},{"key":"10.1038\/s41379-021-00860-4_bib6","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/his.14064","article-title":"Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy","volume":"76","author":"Hollemans","year":"2020","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00860-4_bib7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/bju.12879","article-title":"Disease-specific death and metastasis do not occur in patients with Gleason score <\/=6 at radical prostatectomy","volume":"116","author":"Kweldam","year":"2015","journal-title":"BJU Int"},{"key":"10.1038\/s41379-021-00860-4_bib8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1309\/AJCPZ7WBU9YXSJPE","article-title":"Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome","volume":"136","author":"Iczkowski","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/s41379-021-00860-4_bib9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.eururo.2015.06.046","article-title":"A contemporary prostate cancer grading system: a validated alternative to the Gleason Score","volume":"69","author":"Epstein","year":"2016","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-021-00860-4_bib10","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/bjc.2016.86","article-title":"Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome","volume":"114","author":"Berney","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1038\/s41379-021-00860-4_bib11","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.eururo.2016.11.006","article-title":"New prostate cancer grading system predicts long-term survival following surgery for Gleason Score 8-10 prostate cancer","volume":"71","author":"Ham","year":"2017","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-021-00860-4_bib12","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.urology.2010.01.030","article-title":"Long term-survival after radical prostatectomy for men with high Gleason sum","volume":"76","author":"Pierorazio","year":"2010","journal-title":"Urology"},{"key":"10.1038\/s41379-021-00860-4_bib13","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1200\/JCO.2008.18.2501","article-title":"Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era","volume":"27","author":"Stephenson","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-021-00860-4_bib14","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1097\/PAS.0000000000000691","article-title":"Prognostic significance of percentage and architectural types of contemporary Gleason pattern 4 prostate cancer in radical prostatectomy","volume":"40","author":"Choy","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00860-4_bib15","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1097\/PAS.0b013e3182a02169","article-title":"Architectural heterogeneity and cribriform pattern predict adverse clinical outcome for Gleason grade 4 prostatic adenocarcinoma","volume":"37","author":"Dong","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00860-4_bib16","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.prp.2014.06.002","article-title":"The association of the cribriform pattern with outcome for prostatic adenocarcinomas","volume":"210","author":"Kir","year":"2014","journal-title":"Pathol Res Pr"},{"key":"10.1038\/s41379-021-00860-4_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/modpathol.2014.116","article-title":"Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer","volume":"28","author":"Kweldam","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00860-4_bib18","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.prp.2014.03.003","article-title":"Significance of the cribriform pattern in prostatic adenocarcinomas","volume":"210","author":"Sarbay","year":"2014","journal-title":"Pathol Res Pr"},{"key":"10.1038\/s41379-021-00860-4_bib19","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma","volume":"44","author":"van Leenders","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00860-4_bib20","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.juro.2016.05.105","article-title":"Outcome of Gleason 3 + 5 = 8 prostate cancer diagnosed on needle biopsy: prognostic comparison with Gleason 4 + 4 = 8","volume":"196","author":"Harding-Jackson","year":"2016","journal-title":"J Urol"},{"key":"10.1038\/s41379-021-00860-4_bib21","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/modpathol.2016.49","article-title":"Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy","volume":"29","author":"Kweldam","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00860-4_bib22","doi-asserted-by":"crossref","unstructured":"Hollemans E, Verhoef EI, Bangma CH, Rietbergen J, Osanto S, Pelger RCM, et al. Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients. Mod Pathol. 2021;34:184\u201393.","DOI":"10.1038\/s41379-020-0625-x"},{"key":"10.1038\/s41379-021-00860-4_bib23","first-page":"245","article-title":"Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Buyyounouski","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1038\/s41379-021-00860-4_bib24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part b: prostate and bladder tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-021-00860-4_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41379-018-0157-9","article-title":"Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis","volume":"32","author":"Hollemans","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00860-4_bib26","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0000000000000820","article-title":"Contemporary Gleason grading of prostatic carcinoma: an update with discussion on practical issues to implement the 2014 International Society of Urological Pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma","volume":"41","author":"Epstein","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00860-4_bib27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00428-017-2241-9","article-title":"Evaluation of tumor morphologies and association with biochemical recurrence after radical prostatectomy in grade group 5 prostate cancer","volume":"472","author":"Flood","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1038\/s41379-021-00860-4_bib28","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/PAS.0b013e3182495dee","article-title":"Usual and unusual histologic patterns of high Gleason score 8 to 10 adenocarcinoma of the prostate in needle biopsy tissue","volume":"36","author":"Gottipati","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00860-4_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2017.11.015","article-title":"Tumor necrosis in radical prostatectomies with high-grade prostate cancer is associated with multiple poor prognostic features and a high prevalence of residual disease","volume":"75","author":"Acosta","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00860-4_bib30","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.prp.2018.08.030","article-title":"Comparison of prostatic adenocarcinoma Gleason 5 and intraductal carcinoma of the prostate with tumor necrosis. A morphometric study","volume":"214","author":"Acosta","year":"2018","journal-title":"Pathol Res Pr"},{"key":"10.1038\/s41379-021-00860-4_bib31","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/PAS.0000000000001104","article-title":"Comedonecrosis revisited: strong association with intraductal carcinoma of the prostate","volume":"42","author":"Fine","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00860-4_bib32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/PAP.0000000000000168","article-title":"The new realization about cribriform prostate cancer","volume":"25","author":"Iczkowski","year":"2018","journal-title":"Adv Anat Pathol"},{"key":"10.1038\/s41379-021-00860-4_bib33","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41379-019-0221-0","article-title":"Three-dimensional analysis reveals two major architectural subgroups of prostate cancer growth patterns","volume":"32","author":"Verhoef","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00860-4_bib34","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.eururo.2017.04.034","article-title":"A prostate cancer \u201cnimbosus\u201d: genomic instability and SChLAP1 dysregulation underpin aggression of intraductal and cribriform subpathologies","volume":"72","author":"Chua","year":"2017","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-021-00860-4_bib35","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1158\/1541-7786.MCR-18-0440","article-title":"Genetic and epigenetic determinants of aggressiveness in cribriform carcinoma of the prostate","volume":"17","author":"Elfandy","year":"2019","journal-title":"Mol Cancer Res"},{"key":"10.1038\/s41379-021-00860-4_bib36","first-page":"1113","article-title":"Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization","volume":"10","author":"Qian","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00860-4_bib37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.humpath.2017.04.024","article-title":"PTEN loss and p27 loss differ among morphologic patterns of prostate cancer, including cribriform","volume":"65","author":"Ronen","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00860-4_bib38","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-017-3976-z","article-title":"Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations","volume":"18","author":"Bottcher","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1038\/s41379-021-00860-4_bib39","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.eururo.2006.09.018","article-title":"Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients","volume":"52","author":"Ribeiro","year":"2007","journal-title":"Eur Urol"},{"key":"10.1038\/s41379-021-00860-4_bib40","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-018-1212-6","article-title":"Association of ERG\/PTEN status with biochemical recurrence after radical prostatectomy for clinically localized prostate cancer","volume":"35","author":"Mehra","year":"2018","journal-title":"Med Oncol"},{"key":"10.1038\/s41379-021-00860-4_bib41","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1002\/cncr.27954","article-title":"Genetic markers associated with early cancer-specific mortality following prostatectomy","volume":"119","author":"Liu","year":"2013","journal-title":"Cancer"},{"key":"10.1038\/s41379-021-00860-4_bib42","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/jnci\/djaa032","article-title":"Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN)","volume":"112","author":"Jamaspishvili","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/s41379-021-00860-4_bib43","doi-asserted-by":"crossref","unstructured":"Ahearn TU, Pettersson A, Ebot EM, Gerke T, Graff RE, Morais CL, et al. A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer. J Natl Cancer Inst. 2016;108:djv346.","DOI":"10.1093\/jnci\/djv346"},{"key":"10.1038\/s41379-021-00860-4_bib44","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/ng.2771","article-title":"The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI\/SNF complex","volume":"45","author":"Prensner","year":"2013","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-021-00860-4_bib45","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1016\/j.ejca.2014.08.009","article-title":"Clinico-pathological significance of the molecular alterations of the SPOP gene in prostate cancer","volume":"50","author":"Garcia-Flores","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1038\/s41379-021-00860-4_bib46","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/PAS.0000000000000442","article-title":"Diagnosis of Gleason pattern 5 prostate adenocarcinoma on core needle biopsy: an interobserver reproducibility study among urologic pathologists","volume":"39","author":"Shah","year":"2015","journal-title":"Am J Surg Pathol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00860-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00860-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222005154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222005154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00860-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:34:18Z","timestamp":1760229258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222005154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0893395222005154"],"URL":"https:\/\/doi.org\/10.1038\/s41379-021-00860-4","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-021-00860-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors.","name":"copyright","label":"Copyright"}]}}